Efficacy and Safety of CT-P10 Versus Rituximab in Untreated Low-Tumor-Burden Follicular Lymphoma: Final Results of a Randomized Phase III Study
- Larry W. Kwak
- , Juan Manuel Sancho
- , Seok Goo Cho
- , Hideyuki Nakazawa
- , Junji Suzumiya
- , Gayane Tumyan
- , Jin Seok Kim
- , Tobias Menne
- , José Mariz
- , Nikolai Ilyin
- , Wojciech Jurczak
- , Aurelio Lopez Martinez
- , Olga Samoilova
- , Edvard Zhavrid
- , Eduardo Yañez Ruiz
- , Marek Trneny
- , Leslie Popplewell
- , Michinori Ogura
- , Won Seog Kim
- , Sang Joon Lee
- City of Hope National Med Center
- Generalitat de Catalunya
- Shinshu University
- Shimane University
- Russian Academy of Medical Sciences - N.N. Blokhin Russian Cancer Research Center
- Yonsei University
- Newcastle University
- Instituto Português de Oncologia do Porto Francisco Gentil E.P.E.
- Russian Ministry of Health
- Maria Sklodowska-Curie Institute of Oncology
- Hospital Arnau de Vilanova
- Lobachevsky State University of Nizhni Novgorod
- N. N. Alexandrov Republican Scientific and Practical Centre of Oncology and Medical Radiology
- Universidad de la Frontera
- Charles University
- Toni Stephenson Lymphoma Cancer Center and Department of Hematology and Hematopoietic Cell Transplantation
- Kasugai Municipal Hospital
- Sungkyunkwan University
- Celltrion, Inc.
- Ulm University
Research output: Contribution to journal › Article › peer-review
14
Scopus
citations